HCL Expedites Biocompatibility Failure Investigation to Meet
Regulatory Submission Deadlines
BUSINESS SUCCESS STORY

HCL Expedites Biocompatibility Failure Investigation to Meet Regulatory Submission Deadlines

Pretty much excited to share our team's first business case study over a successful failure investigation for a customer. HCL Material CoE supported them in re-designing their protocols, conducting testing and finally proving the device safety.

The customer is an American multinational leader in Medical Devices. One of its newly developed wearable devices for Cardio-Pulmonary vital measurement failed a biocompatibility test which caused a delay in medical device regulatory submissions and the product launch. HCL’s medical domain experts investigated the test failure by performing root cause analysis through a globally accredited test facility using a unique design of experiments.?Internationally certified HCL biocompatibility and toxicology consultants led the investigation and reporting.?

HCL provides world-class biocompatibility testing support across all classes of medical devices. HCL’s team of well-qualified and certified toxicologists helps customers ensure that their products are safe and compatible.?

For more info: HCL Expedites Biocompatibility Failure Investigation to Meet Regulatory Submission Deadlines | HCL Technologies

PS: Sincere thanks to the co-authors - Mr. Mathiyazhagan M (DU head) and Dr. Mathiyazhagan R (Pre-clinical scientist) for their technical support in successfully decoding the failure.

要查看或添加评论,请登录

Viswanath Srinivasan的更多文章

社区洞察

其他会员也浏览了